Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1.17
  • Today's Change-0.01 / -0.85%
  • Shares traded912.50k
  • 1 Year change-68.72%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Brii Biosciences Ltd is a biotechnology company based in China and the United States principally engaged in developing therapies for infectious diseases. The Company’s products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases, which have significant public health burdens. The Company is also developing therapies for COVID-19 and other diseases.

  • Revenue in HKD (TTM)666.95k
  • Net income in HKD-188.98m
  • Incorporated2017
  • Employees128.00
  • Location
    Brii Biosciences Ltd3rd Floor, Building 7Zhongguancun Dongsheng, InternationalNo. 1 North Yongtaizhuang Road, HaidianBEIJING 100192ChinaCHN
  • Websitehttps://www.briibio.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kintor Pharmaceutical Ltd0.00-1.15bn541.47m225.00--1.09-----2.67-2.670.001.110.000.1448--0.00-72.55-50.15-89.09-58.43---27.62---10,511.412.10--0.3566-------11.15---32.49--
Sirnaomics Ltd0.00-615.15m652.03m145.00--2.08-----8.09-8.090.003.590.00----0.00-70.91---71.22--------------0.6176------10.88------
Antengene Corporation Ltd72.75m-628.24m654.64m201.00--0.5278--9.00-1.02-1.020.11831.840.03580.97733.41361,960.90-30.91-53.57-36.46-58.9481.74---863.51-1,987.016.43--0.1491---57.97--3.38--202.03--
Genor Biopharma Holdings Ltd0.00-728.96m666.47m104.00--0.5096-----1.44-1.440.002.550.000.00--0.00-37.91-55.46-44.02-63.73--66.56---14,819.185.38--0.006---100.00--7.65---48.85--
Lee's Pharmaceutical Holdings Ltd1.05bn16.70m730.16m1.06k43.720.35814.680.69340.02840.02841.793.460.37131.8310.75996,247.900.703313.330.8817.7652.3561.921.8936.200.55263.900.09433.59-14.61-1.53-67.44-47.49-12.19-31.34
Jbm (Healthcare) Ltd610.30m97.99m775.44m258.008.560.82695.211.270.10870.10870.67861.120.44065.884.102,000,994.007.563.339.044.9347.7045.9717.1710.971.4522.150.121113.8128.1114.51131.906.14-5.09--
Transcenta Holding Limited58.21m-500.02m776.75m215.00--0.6974--13.34-1.23-1.230.1432.550.02812.051.49270,738.20-24.17---33.97--26.74---859.01--1.20-32.870.285---47.15---13.72------
Pak Fah Yeow International Ltd259.16m105.04m788.45m102.007.511.037.013.040.3370.3370.83162.460.29952.8822.182,540,765.0012.143.9912.604.1884.4580.7940.5321.276.9010.080.0062100.6876.0612.94250.6623.0218.83-8.06
Zhaoke Ophthalmology Ltd20.27m-416.21m819.21m313.00--0.37--40.42-0.7652-0.76520.03734.050.0075--0.53164,754.11-15.43---17.27--75.98---2,053.54--5.32-47.540.1041------5.47------
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd909.68m160.21m851.58m848.005.320.53226.940.93610.2860.2861.622.860.35872.182.941,072,734.006.327.679.1210.4869.4078.7917.6120.681.51--0.05157.22-0.00495.38-23.43-1.67-1.14--
Brii Biosciences Ltd666.95k-188.98m853.88m128.00--0.2531--1,280.27-0.2598-0.25980.00094.620.0002----5,210.57-5.60---5.84-------29,881.69------0.001---98.80--63.90------
Zhongzhi Pharmaceutical Holdings Ltd2.22bn175.95m863.60m2.64k4.810.7622.990.38980.20770.20772.621.311.122.5310.54838,353.608.957.6914.1511.7559.7360.448.016.730.894--0.142442.4612.2612.4153.0013.8617.653.22
Fusen Pharmaceutical Co Ltd611.40m-39.21m892.45m1.15k--1.47--1.46-0.0525-0.05250.8130.81220.41991.958.36532,579.00-2.690.9678-5.541.7452.9551.95-6.422.590.60960.7560.379727.9515.024.13-4.83--0.2124--
JW (Cayman) Therapeutics Co Ltd187.93m-830.17m965.95m398.00--0.5279--5.14-2.02-2.020.45674.410.07041.6865.54472,190.20-31.11-39.77-35.21-44.0050.74---441.74-1,316.813.86-47.820.1592--19.32--9.23---19.87--
Sunho Biologics Inc-100.00bn-100.00bn1.11bn-------------------------------------------------------155.25------
Hbm Holdings Ltd699.66m178.21m1.12bn177.006.021.145.241.600.24240.24240.95331.280.38863.903.013,952,904.009.88-54.6114.13-66.0497.7397.8125.43-400.283.286.980.3556--120.13127.06116.61---12.62--
Data as of May 31 2024. Currency figures normalised to Brii Biosciences Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

9.81%Per cent of shares held by top holders
HolderShares% Held
Invesco Advisers, Inc.as of 10 Feb 202333.75m4.63%
E Fund Management Co., Ltd.as of 31 Dec 202319.36m2.65%
GF Fund Management Co., Ltd.as of 31 Dec 20236.98m0.96%
Bosera Asset Management Co., Ltd.as of 31 Dec 20225.67m0.78%
UBS Asset Management (Hong Kong) Ltd.as of 28 Mar 20244.54m0.62%
CPIC Fund Management Co. Ltd.as of 31 Dec 2023721.00k0.10%
SSgA Funds Management, Inc.as of 09 May 2024261.00k0.04%
BlackRock Financial Management, Inc.as of 31 Mar 2024123.00k0.02%
American Century Investment Management, Inc.as of 09 May 2024112.00k0.02%
Hwabao WP Fund Management Co., Ltd.as of 31 Dec 202360.50k0.01%
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.